Oral Infigratinib Improves Growth in Children with Achondroplasia, finds NEJM study Dr Riya Dave27 March 2025 9:30 PM ISTResearchers have identified in a new study that oral infigratinib, an FGFR1-3 selective tyrosine kinase inhibitor, improves annualized height velocity...
Oral Infigratinib Promising in Children with Achondroplasia, Increasing Growth with Mild Side Effects: NEJM Medha Baranwal11 Dec 2024 8:45 PM ISTAustralia: A recent study published in the New England Journal of Medicine highlighted the potential benefits of oral infigratinib therapy for...
Jaslok Hospital Doctors perform complex aortic valve replacement surgery in patient with Dwarfism Kajal Rajput27 July 2024 3:00 PM ISTMumbai: Jaslok Hospital and Research Centre, is proud to announce the successful completion of a complex aortic valve replacement surgery in a...
Vosoritide therapy reduces sudden death syndrome in children with achondroplasia: Lancet Dr. Kamal Kant Kohli28 Nov 2023 9:30 AM ISTUSA: Vosoritide given to children with achondroplasia aged 3-59 months for 52 weeks resulted in a gain in the change in height Z score from baseline,...
BioMarin Pharma gets USFDA accelerated approval for Voxzogo for Injection Ruchika Sharma22 Nov 2021 11:00 AM ISTSan Rafael: BioMarin Pharmaceutical Inc. has recently announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to...
First targeted therapy for children with achondroplasia shows persistent height gain Hina Zahid23 March 2021 5:45 AM ISTWASHINGTON - Children with achondroplasia, the most common form of disproportionate short stature, grow taller with trends in improved body...
New drug shown to improve bone growth in children with achondroplasia Hina Zahid18 Sept 2020 5:26 AM ISTA phase three global clinical trial led by the Murdoch Children's Research Institute (MCRI) has shown a new drug boosts bone growth in children born...
